“…The set of sub-mechanisms worked out from Scheme 1 includes, but is not limited to, those of the primary photoprocess with a transparent photoproduct (as for photochromic diarylethenes under visible light ( Crano and Guglielmetti, 2003 ; Nakatani et al, 2016 ; Maafi and Alqarni, 2022 ; Pianowski, 2022 )), the primary photoprocess with an absorbing photoproduct (as for nifedipine, nisoldipine, and dacarbazine drugs ( Tonnesen, 2004 ; Maafi and Maafi, 2013 ; Maafi and Lee, 2015a )), the photoreversible reaction (as for stilbenoids ( Crano and Guglielmetti, 2003 ; Maafi and Al-Qarni, 2019 ), anti-cancer drugs ( Tonnesen, 2004 ; Maafi and Lee, 2015b ), and dimethylhydropropenes ( Ziani et al, 2021 )), the consecutive double photoreversible system (as for fulgides in solution or in the solid state ( Crano and Guglielmetti, 2003 ; Weerasekara et al, 2017 ; Kochman et al, 2022 ; Pianowski, 2022 ) and benzopyrans ( Frigoli et al, 2020 )), the multi-consecutive photoreaction (as for riboflavin ( Maafi and Maafi, 2016 )), and other more complex systems ( Nakatani et al, 2016 ; Scaiano, 2020 ; Malato et al, 2021 ; Pianowski, 2022 ). The mechanisms and molecular systems reviewed previously have been extensively investigated, but their photokinetic studies tended to be either performed by using the equations of thermal kinetics (e.g., first-order exponential models), using various proposed (non-analytical) equations, or employing numerical integration.…”